Retinal Hemorrhage: Clinical Presentation, Diagnostic Evaluation, Management, and Outcomes – A Case Report

Abstract

Retinal hemorrhage is a clinically significant ophthalmic finding characterized by bleeding within the retinal layers due to vascular disruption. It may result from systemic conditions such as hypertension, diabetes mellitus, or localized retinal vascular disorders. Depending on its location and severity, retinal hemorrhage can lead to varying degrees of visual impairment, ranging from mild blurring to sudden vision loss.

We present the case of a 52-year-old male who developed sudden painless diminution of vision in the right eye. Clinical examination and fundoscopic findings revealed multiple flame-shaped retinal hemorrhages associated with hypertensive retinopathy. Prompt systemic and ophthalmologic management led to stabilization of vision and gradual resolution of hemorrhages over time.

This case emphasizes the importance of early diagnosis, comprehensive systemic evaluation, and timely management in preventing permanent visual damage in patients with retinal hemorrhage.

Introduction

Retinal hemorrhages occur when retinal blood vessels rupture or leak, leading to accumulation of blood within different retinal layers. They are broadly classified based on their anatomical location into preretinal, intraretinal, and subretinal hemorrhages. Morphologically, they may present as flame-shaped hemorrhages in the nerve fiber layer or dot-blot hemorrhages in deeper retinal layers.

The etiology of retinal hemorrhage is diverse and includes systemic vascular disorders such as hypertension and diabetes mellitus, retinal vein occlusion, trauma, blood dyscrasias, and coagulopathies. In many cases, retinal hemorrhages serve as an early indicator of systemic disease, making their recognition critical in clinical practice.

Advancements in diagnostic modalities, including fundus photography, optical coherence tomography (OCT), and fluorescein angiography, have enhanced the ability to detect and monitor retinal hemorrhages with precision. Management strategies are directed toward treating the underlying cause and preventing complications such as macular edema or neovascularization.

Case Report

Patient History

A 52-year-old male presented to the ophthalmology clinic with complaints of sudden, painless blurring of vision in the right eye for the past three days. The visual disturbance was not associated with redness, discharge, or photophobia.

The patient reported a history of intermittent headaches over the past six months but had not sought medical attention. He had a known history of hypertension for eight years but admitted to poor compliance with antihypertensive therapy.

There was no history of trauma, diabetes mellitus, bleeding disorders, or use of anticoagulant medications. Family history was unremarkable for ocular or systemic vascular diseases.

Clinical Examination

General Examination

The patient was conscious, alert, and oriented. Vital signs revealed significantly elevated blood pressure at 180/110 mmHg. No signs of anemia, cyanosis, or peripheral edema were observed.

Ophthalmic Examination

Visual acuity testing showed 6/24 vision in the right eye and 6/6 in the left eye. The anterior segment examination was unremarkable in both eyes.

Fundoscopic examination of the right eye revealed multiple flame-shaped hemorrhages along the retinal nerve fiber layer, accompanied by cotton wool spots and generalized arteriolar narrowing. Mild optic disc edema was also noted. The left eye demonstrated early vascular changes, including arteriolar attenuation, but no hemorrhages.

Clinical Evaluation

Differential Diagnosis

Based on the clinical presentation and examination findings, the following differential diagnoses were considered:

• Hypertensive retinopathy (most likely)
• Diabetic retinopathy
• Retinal vein occlusion
• Blood dyscrasia-related retinal hemorrhage
• Traumatic retinal hemorrhage

The absence of diabetes, trauma, and systemic hematological abnormalities, along with markedly elevated blood pressure, strongly supported hypertensive retinopathy as the underlying cause.

Investigations

Ophthalmic Imaging

Fundus Photography:
Revealed multiple flame-shaped hemorrhages radiating along the nerve fiber layer, along with cotton wool spots indicating localized retinal ischemia.

Optical Coherence Tomography (OCT):
Demonstrated retinal thickening with areas of intraretinal fluid accumulation, suggesting vascular leakage.

Fluorescein Angiography:
Showed delayed arterial filling, areas of capillary non-perfusion, and leakage from compromised retinal vessels.

Laboratory Investigations

Routine laboratory investigations were performed to assess systemic status:

• Complete blood count: Within normal limits
• Fasting blood glucose: Normal
• Lipid profile: Elevated low-density lipoprotein (LDL) cholesterol
• Renal function tests: Mild elevation in serum creatinine

These findings indicated underlying systemic vascular compromise associated with poorly controlled hypertension.

Diagnosis

A provisional diagnosis of retinal hemorrhage secondary to hypertensive retinopathy was established based on clinical and imaging findings. The presence of characteristic flame-shaped hemorrhages, cotton wool spots, and vascular narrowing strongly indicated chronic hypertensive vascular damage.

The absence of diabetic microvascular changes, such as microaneurysms or neovascularization, and lack of venous tortuosity helped exclude other causes such as diabetic retinopathy and retinal vein occlusion.

Management and Outcome

Management Strategy

The management approach focused on:

• Aggressive control of systemic hypertension
• Prevention of further retinal vascular damage
• Monitoring for potential complications

Medical Management

The patient was initiated on a strict antihypertensive regimen, including combination therapy for optimal blood pressure control. Lifestyle modifications such as dietary sodium restriction, weight management, and regular physical activity were advised.

Lipid-lowering therapy was also initiated to address dyslipidemia and reduce cardiovascular risk.

Ophthalmic Management

The retinal hemorrhages were managed conservatively with close observation. Anti-vascular endothelial growth factor (anti-VEGF) therapy was considered but deferred due to the absence of significant macular edema.

The patient was counseled regarding the importance of strict systemic control and regular ophthalmic follow-up.

Post-Treatment Course

Over the following weeks, the patient showed gradual improvement in visual acuity and reduction in retinal hemorrhages. Blood pressure levels were successfully controlled with medication adherence.

Follow-Up

At 1 Month

Visual acuity improved to 6/12 in the right eye. Fundoscopic examination showed partial resolution of hemorrhages and reduction in cotton wool spots.

At 3 Months

Significant resolution of retinal hemorrhages was observed. No new lesions were detected, and retinal architecture appeared more stable.

At 6 Months

The patient maintained stable vision with no recurrence of hemorrhages. Blood pressure remained well controlled, and overall functional recovery was excellent.

Discussion

Pathophysiology

Retinal hemorrhages in hypertensive retinopathy occur due to sustained elevation of blood pressure, leading to endothelial damage, increased vascular permeability, and eventual rupture of small retinal vessels. Ischemic injury results in cotton wool spots, while leakage leads to hemorrhage formation.

Etiology and Risk Factors

Common causes of retinal hemorrhage include:

• Systemic hypertension
• Diabetes mellitus
• Retinal vein occlusion
• Trauma
• Hematological disorders
• Anticoagulant therapy

Chronic hypertension remains one of the leading causes, particularly in middle-aged and elderly individuals.

Epidemiology

Retinal hemorrhages are frequently encountered in patients with systemic vascular diseases. Hypertensive retinopathy is more common in individuals with long-standing uncontrolled hypertension and contributes significantly to visual morbidity worldwide.

Clinical Manifestations

The clinical presentation varies depending on severity:

• Sudden painless vision loss
• Blurred vision
• Scotomas or visual field defects
• Asymptomatic in early stages

In this case, the patient presented with typical symptoms of blurred vision associated with hypertensive retinal changes.

Diagnostic Considerations

Diagnosis is primarily clinical, supported by imaging:

1. Fundoscopic examination remains the cornerstone
2. OCT provides detailed structural assessment
3. Fluorescein angiography evaluates vascular integrity

Characteristic findings such as flame-shaped hemorrhages and cotton wool spots aid in diagnosis.

Treatment Considerations

Systemic Management

Effective control of underlying systemic conditions, particularly hypertension, is essential to prevent progression.

Ophthalmic Interventions

In severe cases, treatment options may include:

• Anti-VEGF injections for macular edema
• Laser photocoagulation
• Vitrectomy in cases of non-resolving hemorrhage

Emerging Therapies

Recent advances include:

• Novel anti-VEGF agents with longer duration
• AI-based retinal screening tools
• Regenerative therapies targeting retinal repair

Complications

If untreated, retinal hemorrhages can lead to:

• Permanent vision loss
• Macular edema
• Retinal detachment
• Neovascularization

Prognosis

The prognosis of retinal hemorrhage largely depends on early detection and management of the underlying cause. In cases of hypertensive retinopathy, strict blood pressure control significantly improves outcomes and reduces recurrence risk.

Conclusion

Retinal hemorrhage is an important clinical finding that often reflects systemic vascular pathology. This case illustrates the critical role of early diagnosis, comprehensive evaluation, and timely management in preventing vision-threatening complications.

Control of systemic risk factors, particularly hypertension, remains the cornerstone of treatment. Regular ophthalmic follow-up and patient compliance are essential for long-term visual preservation.

Advancements in diagnostic imaging and therapeutic interventions continue to improve outcomes in patients with retinal vascular diseases.

References

1. Wong TY, Mitchell P. Hypertensive retinopathy. https://pubmed.ncbi.nlm.nih.gov/12617828/
2. Cheung N, et al. Diabetic retinopathy. https://pubmed.ncbi.nlm.nih.gov/23627796/
3. StatPearls. Retinal Hemorrhage Overview. https://www.ncbi.nlm.nih.gov/books/NBK560777/
4. American Academy of Ophthalmology. Retinal vascular diseases. https://www.aao.org/
5. Hayreh SS. Retinal veinlusion. https://pubmed.ncbi.nlm.nih.gov/19671852/
6. Spaide RF, et al. OCT in retinal diseases. https://pubmed.ncbi.nlm.nih.gov/20537310/
7. Klein R, et al. Retinal vascular changes and systemic disease. https://pubmed.ncbi.nlm.nih.gov/16344421/

Read more such content on @ Hidoc Dr | Medical Learning App for Doctors